Legal Update: How New Regulations Affect Your Practice


It seems like regulatory changes occur every week. Some are minor, but others drastically change how we practice. How can you ensure you’ve made the right changes to comply with new and revised USP chapters? This session has you covered. Experts will address differences between the sterile preparation of radioactive and nonradioactive drugs, discuss strategies to ensure compliance, and look at new technologies and proposed changes in sterility and endotoxin testing. 

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Distinguish the similarities and specific differences between USP 797 and USP825.
  2. Describe at least two tactics that can be executed to ensure compliance with USP825.
  3. Recognize new regulatory requirements for testing products for sterility and endotoxin content and explain steps that can be taken to conform to these requirements.

Joint Providership

This activity is approved for Board Certified Nuclear Pharmacist (BCNP) recertification credits.

James Ponto, MS, BCNP, FAPhA
Chief Nuclear Pharmacist and Clinical Professor
University of Iowa Hospitals & Clinics
Kara Weatherman, PharmD, BCNP, FAPhA
Clinical Associate Professor
Purdue University
Learning Level: Level 2
Track: Nuclear Pharmacy
Session Time Slot(s): 
Saturday, March 21
3:00 PM - 6:00 PM
Gaylord National Resort - Chesapeake A-C
ACPE Pharmacist: 0202-0000-20-043-L03-P
CEUs Pharmacist: 0.3
Activity Type: